FRI 127-134 Male Hypogonadism - Causes and Treatments

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Reproductive Endocrinology-Clinical
Friday, March 6, 2015: 1:00 PM-3:00 PM
Hall D-F, Reproductive Endocrinology (San Diego Convention Center)
**This session is NOT eligible for CME credit**


Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany, Mahmoud Nasser, MD, PhD, Dpt. of Gastroenterology, University of Aleppo, Aleppo, Syria, Ahmad Haider, MD, PhD, Private Urology Practice, Bremerhaven, Germany, Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany, Winfried Kurtz, MD, PhD, Dpt. of Internal Medicine, Klinikum Bremerhaven, Bremerhaven, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Monika Fijak, PhD, Justus-Liebig University, Giessen, Germany, Linda Vignozzi, MD, PhD, Sexual Medicine and Andrology, University of Florence, Florence, Italy and Louis J Gooren, MD, PhD, Department of Endocrinology, VU University Medical Center, Amsterdam, Netherlands
Poster Board Number: FRI-127
Ahmad Haider, MD, PhD1, Karim Sultan Haider1, Gheorghe Doros, PhD2, Abdulmaged M Traish, PhD3 and Farid Saad, DVM, PhD4, (1)Private Urology Practice, Bremerhaven, Germany
(2)Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA
(3)Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA
(4)Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-128
Ahmad Haider, MD, PhD1, Karim Sultan Haider1, Gheorghe Doros, PhD2, Abdulmaged M Traish, PhD3 and Farid Saad, DVM, PhD4, (1)Private Urology Practice, Bremerhaven, Germany
(2)Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA
(3)Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA
(4)Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-129
Ahmad Haider, MD, PhD1, Karim Sultan Haider1, Gheorghe Doros, PhD2, Farid Saad, DVM, PhD3 and Abdulmaged M Traish, PhD4, (1)Private Urology Practice, Bremerhaven, Germany
(2)Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA
(3)Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
(4)Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA
Poster Board Number: FRI-130
Ahmad Haider, MD, PhD, Private Urology Practice, Bremerhaven, Germany, Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Abdulmaged M Traish, PhD, Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA and Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-131
Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany, Dany-Jan Yassin, Depertment for Urology and Uro-Oncology, Klinikum Braunschweig, Braunschweig, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Abdulmaged M Traish, PhD, Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA and Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-132
Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany, Yousef Al Mehmadi, MD, PhD, Institute for Urology and Andrology, Norderstedt, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Abdulmaged M Traish, PhD, Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA and Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-133
Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany, Yousef Al Mehmadi, MD, PhD, Institute for Urology and Andrology, Norderstedt, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Abdulmaged M Traish, PhD, Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA and Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
Poster Board Number: FRI-134